Study Reveals Lasting Immune Changes Linked to Obesity and Weight Loss
Obesity may leave a long-lasting biological imprint on the immune system, potentially keeping some health risks elevated for years after weight loss. A 10-year study published in EMBO Reports suggests that people who have lived with obesity can retain a molecular 'memory' of that state in important immune cells. The European research team, led by Professor Claudio Mauro at the University of Birmingham and supported by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre: Birmingham, found that helper T cells, also known as CD4+ lymphocytes, can retain signs of past obesity long after body weight has been reduced. The researchers focused on a process called DNA methylation, where chemical tags or markers attach to DNA inside immune cells. Their findings suggest that these changes may persist for 5 to 10 years following successful weight loss. This lingering 'memory' of obesity in helper T cells could interfere with normal immune functions, affecting processes such as the removal of cellular waste and the regulation of immune aging. According to the researchers, these lasting changes may help explain why individuals who lose weight can remain at increased risk for obesity-related diseases, including type 2 diabetes and certain cancers, even after returning to a normal weight. To build a detailed picture of how obesity affects the immune system, the researchers analyzed immune cells from four different groups of people, including those who had lost weight and those who had not. The study also examined cells from mice models fed a high-fat diet, along with blood donations from healthy human volunteers. These additional models helped the researchers investigate the cellular mechanisms that contribute to immune dysregulation in obesity. Professor Claudio Mauro stated, "The findings suggest that short-term weight loss may not immediately reduce the risk of some disease conditions associated with obesity. Instead, ongoing weight management following loss will see the 'obesity memory' slowly fade. This may take several years of sustained weight loss maintenance, likely 5 to 10 years, though this requires further study to fully reverse the effects of obesity on T cells." The researchers identified two biological pathways influenced by these lasting DNA changes in helper T cells: autophagy, where cells consume damaged or unnecessary material, and immune senescence, which refers to the aging of the immune system. The team plans to use these findings to investigate targeted therapies that could restore normal immune activity when disrupted by obesity-related DNA tagging. Such treatments could potentially be used alongside existing weight loss therapies to lower the risk of metabolic diseases, cancer, and other conditions worsened by obesity. Dr. Belinda Nedjai from the Wolfson Institute of Population Health at Queen Mary University London, a senior author of the paper, noted, "Our findings show that obesity is associated with durable epigenetic modifications that influence immune cell behavior. This suggests that the immune system retains a molecular record of past metabolic exposures, which may have implications for long-term disease risk and recovery." Professor Andy Hogan from the Kathleen Lonsdale Institute for Human Health Research at Maynooth University Ireland added, "We know obesity is a chronic progressive and relapsing disease, and our findings provide further understanding of the molecular mechanisms potentially driving the risk of relapsing, highlighting the challenges facing individuals living with obesity in successfully managing their weight." The study was conducted through the NIHR Biomedical Research Centre: Birmingham, which supports research aimed at improving outcomes for people living with multiple long-term conditions. Materials provided by University of Birmingham.




